MoneyWorks4Me

Biofil Chemicals & Pharmaceuticals informs about details of loss of certificate

07 Jul 2022 Evaluate
Pursuant to the provision of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, Biofil Chemicals & Pharmaceuticals has informed that Company has received intimation from its Registrar & Share Transfer Agent on 6th July, 2022 regarding loss of Share Certificate(s) by respective shareholder. Pursuant to SEBI Circular Number SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022 a letter of confirmation will be issued to the shareholders only after the receipt of all necessary documents and compliance of required formalities.

The above information is a part of company’s filings submitted to BSE.

Biofil Chem & Pharma Share Price

32.25 -0.30 (-0.92%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 349.40
Amrapali Industries 35.77
Adani Enterprises 3007.00
Rashi Peripheral 893.80
PDS 361.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: